Abstract
The purpose of the study was to prospectively assess magnetic resonance (MR) imaging findings of lower limb musculature in an axonal Charcot-Marie-Tooth disease (CMT2) pedigree due to mutation in the dynamin 2 gene (DNM2). The series comprises a proband patient aged 55 years and her two affected daughters aged 32 and 23. MR imaging study included T1- and fat suppressed T2-weighted spin-echo sequences. MR imaging study showed extensive fatty infiltration of all calf muscle compartments with relative preservation of the deep posterior one. Fatty muscle infiltration increased distally in 19 out of 66 (23 %) visualized calf muscles in the three patients, but this percentage increased to 64 % in the youngest and least severe patient. Muscle edema without contrast enhancement was present in 23 % of calf muscles. There was massive fatty atrophy of foot musculature. We conclude that MR imaging study accurately depicts lower limb muscle involvement in CMT2 caused by DNM2 mutation.
Similar content being viewed by others
References
Berciano J, Combarros O, Figols J, Calleja J, Cabello A, Silos I, et al. (1986) Hereditary motor and sensory neuropathy type II. Clinicopathological study of a family. Brain 109:897–914
Berciano J, García A, Calleja J, Combarros O (2000) Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot-Marie-Tooth disease 1A duplication. Neuromuscul Disord 10:419–424
Berciano J, Gallardo E, García A, Infante J, Mateo I, Combarros O (2006) Charcot-Marie-Tooth disease type 1A duplication with severe paresis of the proximal lower limb muscles. A longterm follow-up study. J Neurol Neurosurg Psychiatry 77:1169–1176
Bitoun M, Maugenre S, Jeannet PY, Lacène E, Ferrer X, Laforrêt P, et al. (2005) Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet 37:1207–1209
Combarros O, Calleja J, Polo JM, Berciano J (1987) Prevalence of hereditary motor and sensory neuropathy in Cantabria, Spain. Acta Neurol Scand 75:9–12
Fabrizi GM, Ferrarini M, Cavallaro T, Cabrini I, Cerini R, Bertolasi L, et al. (2007) Two novel mutations in dynamin-2 cause axonal Charcot-Marie- Tooth disease. Neurology 69:291–295
Fischer D, Herasse M, Bitoun, Barragán-Campos HM, Chiras J, Laforêt P, et al. (2006) Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy. Brain 129:1463–1469
Fleckenstein JL, Watumull D, Conner, Ezaki M, Greenlee RG, Bryan WW, et al. (1993) Denervated human skeletal muscle: MR imaging evaluation. Radiology 187:213–218
Gabreëls-Festen AA, Joosten EM, Gabreëls FJ, Jennekens FG, Janssen-van Kempen TW (1992) Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN) type 1. J Neurol Sci 107:45–54
Gabriel CM, Gregson NA, Wood NW, Hughes RAC (2002) Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN type I). J Neurol Neurosurg Psychiatry 72:230–235
Gallardo E, García A, Combarros O, Berciano J (2006) Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles. Brain 129:426–437
García A, Combarros O, Calleja J, Berciano J (1998) Charcot-Marie- Tooth disease type 1A with 17p duplication in early infancy and childhood. A longitudinal clinical and electrophysiological study. Neurology 50:1061–1067
Ginsberg L, Malik O, Kenton AR, Sharp D, Muddle JR, Davis MB, et al. (2004) Coexistent hereditary and inflammatory neuropathy. Brain 127:193–202
Goutallier D, Postel JM, Bernageau J, Lavau L, Voisin MC (1994) Fatty muscle degeneration in cuff ruptures. Pre- and postoperative evaluation by CT scan. Clin Orthop Res 304:78–83
Harding AE, Thomas PK (1980) The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103:259–280
Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer Sr, Garbern J, et al. (2000) Neuronal dysfunction and axonal degeneration in Charcot-Marie- Tooth disease type 1A. Brain 123:1516–1527
Martini R, Berciano J, Van Broeckhoven C (2000) 5th Workshop of the European CMT Consortium, 69th ENMC International Workshop: therapeutic approaches in CMT neuropathies and related disorders, 23–25 April 1999, Soestduinen, The Netherlands. Neuromuscul Disord 10:69–74
May DA, Disler DG, Jones EA, Balkissoon AA, Manaster BJ (2000) Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. RadoGraphics 20:S295–S313
Mercuri E, Jungbluth H, Muntoni F (2005) Muscle imaging in clinical practice: diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders. Curr Opin Neurol 18:526–537
Nicholson GA (2006) The dominantly inherited motor and sensory neuropathies: clinical and molecular advances. Muscle Nerve 33:589–597
Nicholson G, Myers S (2006) Intermediate forms of Charcot-Marie-Tooth disease. NeuroMolecular Med 8:123–130
Pichiecchio A, Uggetti C, Egitto MG, Berardinelli A, Orcesi S, Gorni KO, et al. (2002) Quantitative MR evaluation of body composition in patients with Duchenne muscular atrophy. Eur Radiol 12:2704–2709
Reilly MM, De Jonghe P, Pareyson D (2006) 136th ENMC International Workshop: Charcot-Marie-Tooth disease type 1A (CMT1A), 8–10 April 2005, Naarden, The Netherlands. Neuromuscul Disord 16:396–402
Schessl J, Medne L, Hu Y, Zou Y, Brown MJ, Huse JT, et al. (2007) MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement. Neuromuscul Disord 17:28–32
Stillwell G, Kilcoyne RF, Sherman JL (1995) Patterns of muscle atrophy in the lower limbs in patients with Charcot-Marie-Tooth disease as measured by magnetic resonance imaging. J Foot Ankle Surg 34:583–586
Vinci P, Serrao M, Pierelli F, Sandrini G, Santilli V (2006) Lower limb manual muscle testing in the early stages of Charcot-Marie-Tooth disease type 1A. Functional Neurol 21:159–163
West GA, Haynor DR, Goodkin R, Tsuruda JS, Bronstein AD, Kraft G, et al. (1994) Magnetic resonance imaging signal changes in denervated muscles after peripheral nerve injury. Neurosurgery 35:1077–1085
Züchner S, Noureddine M, Kennerson M, Verhoeven K, Claeys K, De Jonghe P, et al. (2005) Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet 37:289–294
Züchner S, Vance JM (2006) Molecular genetics of autosomal-dominant axonal Charcot-Marie-Tooth disease. NeuroMolecular Med 8:63–74
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gallardo, E., Claeys, K.G., Nelis, E. et al. Magnetic resonance imaging findings of leg musculature in Charcot-Marie-Tooth disease type 2 due to dynamin 2 mutation. J Neurol 255, 986–992 (2008). https://doi.org/10.1007/s00415-008-0808-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-008-0808-8